Feed aggregator

6 Recently Approved Cell & Gene Therapies—And Why They Matter

Biospace news - Thu, 01/04/2024 - 02:00
6 Recently Approved Cell & Gene Therapies—And Why They Matter 4/1/2024

FDA Action Alert: Vanda, Basilea and J&J/Legend

Biospace news - Thu, 01/04/2024 - 02:00
FDA Action Alert: Vanda, Basilea and J&J/Legend 4/1/2024

Healthy omega-3 fats may slow deadly pulmonary fibrosis

World Pharma News - Wed, 01/03/2024 - 11:00
Could healthy fats found in nuts and fish slow the progression of potentially deadly lung scarring known as pulmonary fibrosis and delay the need for lung transplants?

UVA pulmonary researchers looked at the association between blood-plasma levels of omega-3 fatty acids - the heart-healthy fats found in foods such as salmon and flaxseeds - and the progression of pulmonary fibrosis, as well as how long patients could go without needing a transplant.

Newly discovered genetic mutation protects against Parkinson's disease

World Pharma News - Tue, 01/02/2024 - 11:00
A previously unidentified genetic mutation in a small protein provides significant protection against Parkinson's disease and offers a new direction for exploring potential treatments, according to a new USC Leonard Davis School of Gerontology study.

The variant, located in a mitochondrial microprotein dubbed SHLP2, was found to be highly protective against Parkinson’s disease; individuals with this mutation are half as likely to develop the disease as those who do not carry it.

Want to quit smoking in 2024?

World Pharma News - Mon, 01/01/2024 - 11:00
A new study published in Addiction has found that cytisine, a low-cost, generic stop-smoking aid that has been used in eastern Europe since the 1960s, increases the chances of successful smoking cessation by more than two-fold compared with placebo and may be more effective than nicotine replacement therapy. It has a benign safety profile, with no evidence of serious safety concerns.

Oral peptides: A new era in drug development

World Pharma News - Fri, 12/29/2023 - 11:00
For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy. Traditional small molecules often struggle to bind to proteins with flat surfaces or require specificity for particular protein homologs. Typically, larger biologics that can target these proteins demand injection, limiting patient convenience and accessibility.